1004 Venture Partners

1004 Venture Partners is a specialist venture capital firm investing in companies addressing healthy ageing across the lifespan. Its remit spans health technology, age technology, healthcare infrastructure, biotech, medtech and digital health, with stated areas of interest including AI-enabled therapeutics, intelligent medical devices, ageing-in-place infrastructure and longevity. The firm invests at both early and later stages; check sizes, fund structure and founding date are not disclosed in its published materials.

Beyond capital, the firm provides founder support built around mentorship, strategic guidance and network access. Portfolio companies are connected to investors, clinical experts, academic research hubs and industry professionals, with the stated aim of helping them reach clinical, regulatory and commercial milestones. The investment approach combines scientific diligence with operational experience, and the partnership style is described as hands-on and collaborative.

The firm frames its mandate as improving the experience of ageing alongside pursuing venture returns. In a market where longevity and age-tech investing has increasingly intersected with digital health and healthcare infrastructure, 1004 Venture Partners concentrates on a single thematic vertical rather than a generalist portfolio.